185 related articles for article (PubMed ID: 29450492)
1. Do All Patients Need β-Blockers After a Heart Attack?
Abbasi J
JAMA; 2018 Mar; 319(9):853-855. PubMed ID: 29450492
[No Abstract] [Full Text] [Related]
2. Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction.
Makam RC; Erskine N; McManus DD; Lessard D; Gore JM; Yarzebski J; Goldberg RJ
Am J Cardiol; 2016 Dec; 118(12):1792-1797. PubMed ID: 27743577
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacotherapy after cardiac infarction].
Darius H; Meyer J
Internist (Berl); 2001 May; 42(5):699-712. PubMed ID: 11400577
[No Abstract] [Full Text] [Related]
4. Adding ACE inhibitors or ARBs to standard therapy for stable ischemic heart disease.
Guirguis-Blake J
Am Fam Physician; 2012 Jul; 86(1):21-3. PubMed ID: 22962909
[No Abstract] [Full Text] [Related]
5. Commentary on NICE guidance for secondary prevention for patients following a myocardial infarction.
Skinner JS; Minhas R
Heart; 2007 Jul; 93(7):864-6. PubMed ID: 17569812
[No Abstract] [Full Text] [Related]
6. Secondary prevention following myocardial infarction: a clinical update.
Isted A; Williams R; Oakeshott P
Br J Gen Pract; 2018 Mar; 68(668):151-152. PubMed ID: 29472228
[No Abstract] [Full Text] [Related]
7. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
[TBL] [Abstract][Full Text] [Related]
8. Impact of secondary prevention medical therapies on outcomes of patients suffering from Myocardial Infarction with NonObstructive Coronary Artery disease (MINOCA): A meta-analysis.
De Filippo O; Russo C; Manai R; Borzillo I; Savoca F; Gallone G; Bruno F; Ahmad M; De Ferrari GM; D'Ascenzo F
Int J Cardiol; 2022 Dec; 368():1-9. PubMed ID: 35987312
[TBL] [Abstract][Full Text] [Related]
9. Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes.
Choudhry NK; Glynn RJ; Avorn J; Lee JL; Brennan TA; Reisman L; Toscano M; Levin R; Matlin OS; Antman EM; Shrank WH
Am Heart J; 2014 Jan; 167(1):51-58.e5. PubMed ID: 24332142
[TBL] [Abstract][Full Text] [Related]
10. Medical management after myocardial infarction.
Aronow WS
Future Cardiol; 2019 May; 15(3):135-138. PubMed ID: 31148480
[No Abstract] [Full Text] [Related]
11. [Pharmacological prevention of coronary relapses in Italian clinical practice: a literature review].
Pedrinelli R; Ciccone M; Novo S; Catapano AL
G Ital Cardiol (Rome); 2012 Nov; 13(11):734-40. PubMed ID: 23096582
[TBL] [Abstract][Full Text] [Related]
12. Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial.
Fanaroff AC; Peterson ED; Kaltenbach LA; Cannon CP; Choudhry NK; Henry TD; Anstrom KJ; Cohen DJ; Fonseca E; Khan ND; Fonarow GC; Wang TY
JAMA Cardiol; 2020 Jan; 5(1):38-46. PubMed ID: 31721978
[TBL] [Abstract][Full Text] [Related]
13. Guidelines and registries: secondary prophylaxis after AMI with emphasis on the use of beta-blockers and ACE inhibitors.
Otterstad JE
Scand Cardiovasc J; 2005 Apr; 39(1-2):10-2. PubMed ID: 16097408
[No Abstract] [Full Text] [Related]
14. Usefulness of an acute coronary syndrome pathway to improve adherence to secondary prevention guidelines.
Biviano AB; Rabbani LE; Paultre F; Hurley E; Sullivan J; Giglio J; Mosca L
Am J Cardiol; 2003 May; 91(10):1248-50. PubMed ID: 12745113
[No Abstract] [Full Text] [Related]
15. Secondary prevention for patients following a myocardial infarction: summary of NICE guidance.
Skinner JS; Cooper A; Feder GS;
Heart; 2007 Jul; 93(7):862-4. PubMed ID: 17569811
[TBL] [Abstract][Full Text] [Related]
16. Re: Secondary medical prevention in patients with peripheral arterial disease.
Schouten O; Welten GM; Bax JJ; Poldermans D
Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
[No Abstract] [Full Text] [Related]
17. Ask the doctor. I had a heart attack three years ago at age 78. My doctor started me on lisinopril, carvedilol, and aspirin. My total cholesterol is 190, and my LDL is 128. Should I be taking a statin?
Lee R
Harv Heart Lett; 2011 Aug; 21(12):7. PubMed ID: 21991614
[No Abstract] [Full Text] [Related]
18. Association Between Preadmission Functional Status and Use and Effectiveness of Secondary Prevention Medications in Elderly Survivors of Acute Myocardial Infarction.
Chrischilles EA; Schneider KM; Schroeder MC; Letuchy E; Wallace RB; Robinson JG; Brooks JM
J Am Geriatr Soc; 2016 Mar; 64(3):526-35. PubMed ID: 26928940
[TBL] [Abstract][Full Text] [Related]
19. Primary prevention of myocardial infarction: putting the evidence to use.
Herzog E; Javed F
Arch Intern Med; 2010 Aug; 170(15):1381-2. PubMed ID: 20696965
[No Abstract] [Full Text] [Related]
20. [Secondary prevention after cardiac infarct; therapeutic efficiency--cost-benefit ratio].
Kreuzer J; Kübler W
Internist (Berl); 2001 May; 42(5):713-9. PubMed ID: 11400578
[No Abstract] [Full Text] [Related]
[Next] [New Search]
